This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Intrauterine Embryo Development With ANECOVA Device (ANECOVA)

This study has been terminated.
Anecova SA
Information provided by:
Instituto Valenciano de Infertilidad, IVI VALENCIA Identifier:
First received: May 28, 2007
Last updated: March 3, 2011
Last verified: March 2011
We aim to compare the morphological and chromosomal features of human embryos cultured In Vitro versus those developed in a new In Vivo culture system with encapsulation in utero as well as implantation and pregnancy rate.

Condition Intervention Phase
Healthy Device: in vivo (ANECOVA D-1) or in vitro culture in 25-µl droplets of cleavage medium (Medicult®) under paraffin oil Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Screening
Official Title: Multi-Center Evaluation Program NCVD1H Intrauterine Embryo'S Development Assisted by ANECOVA ACVd1 Device

Further study details as provided by Instituto Valenciano de Infertilidad, IVI VALENCIA:

Study Start Date: August 2007
Study Completion Date: November 2008
Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 36 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Women age below 37
  • Hormonal serum levels within normal ranges (FSH, LH, E2, PRL, P4, T4, TSH)
  • Negative serologic screening for HIV, Hep B and C
  • No uterine or ovarian alterations found by ultrasound
  • Normal BMI (19 - 29 kg/m2).

Exclusion Criteria:

  • At least 8 stage MII oocytes are not retrieved
  • Endometriosis or PCO
  • Severe male factor in the partner
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00480103

Instituto Valenciano de Infertilidad Spain
Valencia, Spain, 46015
Sponsors and Collaborators
Instituto Valenciano de Infertilidad, IVI VALENCIA
Anecova SA
Study Director: Martin Velasco Affiliated
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Dr Carlos Simon, Instituto Valenciano de Infertilidad Identifier: NCT00480103     History of Changes
Other Study ID Numbers: NCVD1H
Study First Received: May 28, 2007
Last Updated: March 3, 2011

Keywords provided by Instituto Valenciano de Infertilidad, IVI VALENCIA:
Embryo morphological and chromosomal features
Implantation and pregnancy rate processed this record on August 21, 2017